Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Bioarctic, Eisai, Fondazione Telethon, Halozyme, Janssen-Cilag, Ocugen, Spur, United.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femasys, Gyder, Rapidai.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Apellis, Akeso, Astrazeneca, Biogen, Clearside, CSL Behring, GSK, Iaso, Impact, Innovent, Junshi, Kalvista, Telix, Vyluma, Zai Lab.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Axsome, Bavarian Nordic, BMS, Celltrion, Daiichi Sankyo, Merck, Pfizer, Sanofi, Vertex, Viiv, Zai Lab.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bioretec, Essilorluxottica, Roche.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Comanche, Dilafor, Karolinska, Ironwood, March.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Emmaus, Iaso, Novo Nordisk, Scholar Rock, Vicore, Vyluma, Zhaoke.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Curonix, Life Spine, Orthopreserve, Synthetic MR.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: GE Healthcare, Roche.